Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

One-pot synthesis of laurolactam from cyclododecene and air

Susi Hervàs-Arnandis , Silvia Rodríguez-Nuévalos , Judit Oliver-Meseguer * and Antonio Leyva-Pérez *
Instituto de Tecnología Química (Universitat Politècnica de València–Agencia Estatal Consejo Superior de Investigaciones Científicas), Avda. de los Naranjos s/n, 46022 València, Spain. E-mail: joliverm@itq.upv.es; anleyva@itq.upv.es

Received 3rd October 2025 , Accepted 4th November 2025

First published on 6th November 2025


Abstract

Laurolactam is an essential compound for the synthesis of polyamides and requires four separated steps for its industrial production, starting from cyclododecane. Here we show a one-pot synthesis of laurolactam from cyclododecene, without intermediate purifications, in 66% yield. If desired, the intermediate cyclododecanone oxime can also be isolated, and the procedure is applicable for the production of caprylolactam.


Laurolactam 1 is the monomer used for the production of Nylon-12™,1 which has a market that exceeds 100[thin space (1/6-em)]000 tons per year and the sales account for >$1.5 billion worldwide, expected to reach >$2.0 billion by 2030. Therefore, efficient production of laurolactam is essential to lower the price and the ecological footprint of Nylon-12™ in order to reach a sustainable global production for the coming years.

Fig. 1 shows the current industrial synthesis of laurolactam 1, which is based on the Beckmann rearrangement reaction of cyclododecanone oxime 2, catalyzed by sulfuric acid. The purified cyclododecanone oxime 2 is in turn obtained by the oximation reaction of cyclododecanone 3, and this ketone is produced in low yield (typically 5%) by a Co-catalyzed aerobic oxidation of cyclododecane 4, resulting in a mixture of ketone 3 and alcohol 5, which needs to be purified.2 Ultimately, the starting cyclododecane 4 comes from cyclododecatriene 6, obtained by the butadiene trimerization reaction. All these steps require individual purification processes to isolate the intermediates, since either the catalysts used, the excess of reactants or certain unwanted by-products lead to the partial or total inhibition of the next reaction along the established synthetic pathway. Therefore, it is not surprising that a high number of studies have been devoted during recent years to alleviating the issues associated to laurolactam 1 production, with some of them trying to join some steps of the manufacture route.3 However, the success of these approaches is somewhat limited due to the difficulties in obtaining pure cyclododecanone 3 during the direct oxidation of cyclododecane 4.4


image file: d5cy01180a-f1.tif
Fig. 1 The current industrial route for laurolactam 1 synthesis, and the route herein reported. Solid arrows indicate a chemical transformation in a reactor and dashed arrows indicate the need for intermediate purification steps. Bracketed intermediates occur in a single reactor and do not need to be isolated.

An alternative route for the introduction of the oxygen atom into the twelve-carbon atom cycle is the epoxidation of cyclododecene 7, as also shown in Fig. 1. This mono-alkene can be obtained by selective hydrogenation of cyclododecatriene 6 (such as cyclododecane 4) and, in contrast to the latter, other efficient synthetic routes are available for the production of cyclododecene 7.5 Thus, cyclododecene 7 can be considered as a potential starting material to synthesize laurolactam 1. Unfortunately, the second step for the synthesis of 1 from 7, i.e. the epoxidation reaction to obtain epoxide 8, has been mainly described with either m-chloroperbenzoic acid,6 hydrogen peroxide7a (H2O2) and nitrous oxide7b N2O as oxidizing reagents, in excess, or in the presence of homogeneous catalysts based on tungsten, titanium or other transition metals.8 These reaction conditions, in addition to the economic and environmental burden associated to the use of those epoxidating agents instead of air, are incompatible with the subsequent Meinwald rearrangement reaction to obtain cyclododecanone 3, thus making a one–pot, single step reaction unfeasible3,9 to achieve laurolactam 1 from cyclododecene 7.

At this point, we wondered if it would be possible to directly oxidize cyclododecene 7 to the epoxide 8 with air in good yields, without any catalyst,10 and make this oxidizing system compatible for the next steps of the synthetic pathway, i.e., the reactions of Meinwald transposition to ketone, and the oximation and transposition reactions to the lactam. In fact, the aerobic oxidation of cyclododecene 7 to the corresponding epoxide has been described, but using various catalysts, such as a combination of a Cu catalyst and 2,2,6,6-tetramethylpiperidinyloxy (TEMPO),10b and with overoxidized by-products in all cases.11 However, the selective epoxidation reaction of cyclododecene 7 occurs without a catalyst on the basis of our recent study on the aerobic epoxidation of alkyl alkenes12 and also in, at least, another precedent for the aerobic epoxidation of cyclododecene13a and the related molecule cyclohexene.13b The epoxidation yield in the latter is very low (less than 10%) due to the excessive formation of over–oxygenated products,13c thus, we were positive in that our recent aerobic procedure,12 which gives >90% of cyclododecene epoxide 8, would be compatible with the designed cascade reaction. In our case, we make use of the alkene aggregation effect at high concentrations for better reactivity against oxygen,13d to avoid the use of high oxygen pressures and also the use of any solvent, and both improvements will make the next transposition reaction more compatible (see “Further comments on literature precedents” in the SI).

In our previous study,12 we showed that the results for the uncatalyzed aerobic epoxidation reaction of cyclododecene 7 under neat oxygen (autoclave or bubbling) or just atmospheric air (open flask conditions) gave cyclododecene epoxide 8 as the major product with yields up to 80%. It is worthy to comment here that all reactions were carried out in glass reactors, avoiding any metal in contact with the reaction mixture, a key difference of our recently reported method compared to the previous literature.10 Kinetic experiments show12 that the epoxidation reaction smoothly occurs after an induction time, and that the selectivity towards product 8 is somewhat lost at high conversions and temperatures (Fig. S1), since ozone and oxygen free radicals are generated as by-products and start to break the epoxide. The formation of ozone during the reaction was checked by an in situ UV-vis reactivity test with indigo as a probe molecule, since the disappearance of the indigo absorption band at 604 nm together with the appearance of the band at 320 nm corresponding to the oxidation product with ozone is only observed when cyclododecene 7 was present in the reaction mixture.12 Nevertheless, >99% selectivity to 8 is obtained in diluted air (66% yield of 8, Fig. S2) which, strictly complies with the industrial requirement of operating under reaction conditions below the flammability limits of cyclododecene 7.14 The verification that O2 was the source of O atoms for the epoxide during the reaction was carried out with isotopically labelled reactive experiments employing 36O2 instead of normal 32O2, since the isotopically labelled epoxide product 18O–8 was found by both gas chromatography coupled with mass spectrometry (GC–MS) and Fourier-transformed infrared spectroscopy measurements (FT-IR),12 with the expected isotopic mass and infrared shift, respectively. Indeed, an open bottle of cyclododecene 7 in the laboratory can contain >5% of cyclododecene epoxide 8 and other overoxidized products (Fig. S3), in virtue of the natural oxidation with air during time, a feature barely commented in the literature. Kinetic experiments showed that cyclododecene 7 is reactive in either cis or trans form (the commercial sample employed here is 3[thin space (1/6-em)]:[thin space (1/6-em)]1 cis[thin space (1/6-em)]:[thin space (1/6-em)]trans), although the former seems somewhat more reactive (Fig. S4 and Table S1). In any case, it must be noted that the isomeric form of the epoxide 8 is in principle irrelevant for the next reaction during the one-pot synthesis, i.e. the formation of cyclododecanone 3.

Cyclooctene 9 also gave the corresponding epoxide 10 in high yield (79%) under the optimized reaction conditions (Fig. S5) but, in contrast, cyclohexene 11 only gave a 4% of cyclohexene epoxide 12, since most of the product comes from the classical allylic oxidation reaction, to give cyclohexenone 13.15a These results reflect the subtle structure–reactivity relationship operating during the uncatalyzed aerobic oxidation of cyclic alkenes, apparently favouring the desired epoxidation reaction for macrocyclic alkenes such as cyclododecene 7 (see density functional theory, DFT, calculations ahead),15b something not studied in our previous study.12 This result nicely fits the results obtained in a two-pot epoxidation experiment where neat cyclododecene 7 was treated with bubbled O2 before the O2 flow reaches a second flask with unreactive neat 1-tetradecene 14 (Fig. S6), to show that the terminal alkene 14 is epoxidized with air only after passing through cyclododecene 7. This reactivity is explained by the higher electronic richness of the internal alkene 7 after aggregating in neat form (without any solvent),13d in order to activate O2 for the epoxidation reaction (see the qualitative Fig. S7, investigated by DFT ahead).

Once we know that cyclododecene 7 is converted to cyclododecene epoxide 8 with just air and without any other additive, catalyst or solvent needed, we tested the one-pot formation of cyclododecanone 3 by a Meinwald transposition reaction. This reaction converts epoxides to ketones with either acidic catalysts or inorganic salts16 which, in principle, could be compatible with our mild air-based epoxidation conditions. In this way, we would completely avoid the formation of cyclododecanol 5, which inevitably occurs during the current cyclododecane 4 oxidation route. The results in Table 1 shows that a variety of simple and cheap salts are able to convert the in situ formed cyclododecene epoxide 8 into cyclododecanone 3, in reasonable yields, particularly LiBr (entry 2), LiI (entry 3) and NaI (entry 6). The catalytic action of hydroxylamine hydrochloride (NH2OH·HCl, entry 8, industrially used for the oximation reaction)17 is also remarkable since this will be the reagent for the next reaction step in the sequence, i.e. the oximation reaction and, indeed, a 32% of cyclododecanone oxime 2 is observed. Other salts gave poor selectivity to 3 (entries 1 and 5) or poor conversion (entries 4 and 7), the by-products being over-oxidated or oxidative breaking products. The addition of an active salt with poor selectivity (for example NaBr, entry 4) after the epoxidation reaction had been completed, i.e. as a sequential reaction, improved significantly the conversion and selectivity (Table S2), to achieve a 75% of cyclododecanone 3. These results indicate that the one-pot synthesis of cyclododecanone 3 from cyclododecene 7 can be achieved in good yields either by a cascade or sequential one-pot procedure.

Table 1 Results for the formation of cyclododecanone 3 after one-pot aerobic oxidation of cyclododecene 7 and Meinwald rearrangement of the in situ formed cyclododecene epoxide 8, at 200 °C for 16 h, in the presence of different catalytic salts (4.5 mol%)

image file: d5cy01180a-u1.tif

Entry Salt Conv. of 7 (%) Yield (%)
8 3
a In parentheses, result after adding the salt to the previously formed epoxide 8 (200 °C, 2 h). b The mass balance is completed with cyclododecanone oxime 2.
1 LiCl 80 60 17
2 LiBr 58 4 44 (85)
3 LiI 63 5 56
4 NaCl 43 36 7
5a NaBr 82 18 20 (75)
6 NaI 72 12 60
7 KI 40 23 17
8b NH 2 OH·HCl 62 0 28


The next reactions to achieve laurolactam 1 are the oximation of cyclododecanone 3 and the Beckmann transposition. As we have shown above, NH2OH·HCl can act as catalyst of the Meinwald transposition as a reagent of the oximation reaction. The participation of the Meinwald transposition in tandem reactions has been described,18a but not for the cascade reaction shown here. The Beckmann transposition is performed in the industry with sulfuric acid, resulting in a large amount of sulfated salts and wastewater as by-products of the reaction.18b However, milder acidic catalysts such as ZnO (ref. 18c) have been described to catalyze the reaction,18d,e including combinations of organic acids and inorganic salts.18b At this point, we thought that the addition of the simple metal salt ZnO will be enough to catalyze the Beckmann transposition with the help of NH2OH·HCl and the small amounts of carboxylic acids generated during the aerobic epoxidation stage. The result, shown in Fig. 2, confirms that a 66% yield of laurolactam 1 is obtained from cyclododecene 7 when the reaction is run sequentially (Fig. S8 and S9) with a 55% of isolated yield starting from 5 mmol of cyclododecene 7. If desired, cyclododecanone oxime 2 can be obtained in 67% yield if ZnO is not added and acetonitrile is employed as a solvent,19a and the reaction temperature is decreased.


image file: d5cy01180a-f2.tif
Fig. 2 Result for the sequential one-pot reaction to achieve either laurolactam 1 or cyclododecanone oxime 2 from cyclododecene 7.

The same sequential reaction protocol was then tested to achieve cyclooctanone oxime 15 and caprylolactam 16 from cyclooctene 9, since the latter also reacts well during the uncatalyzed aerobic epoxidation reaction. The result in Fig. 3 shows that cyclooctanone oxime 15 can be obtained in an overall 45% yield (Fig. S10) with a 39% of isolated yield, however, caprylolactam 16 was only obtained in <10% yield under these reaction conditions or other conditions tested (Fig. S11 and Table S3).


image file: d5cy01180a-f3.tif
Fig. 3 Result for the sequential one-pot reaction to achieve cyclooctanone oxime 15 or caprylolactam 16 from cyclooctene 9. All yield results refer to gas chromatography (GC) yields, checked also by mass spectrometry (GC–MS) and using dodecane as an external standard.

DFT calculations were performed in order to understand the reactive differences observed for the three different cyclic alkenes 7, 9 and 11. First, the relative energy of the starting alkenes, the epoxide products, the classical allylic radical hydroperoxides19b,c and our recently proposed perepoxide intermediate products19d,e were computed, and there is an observable energetic compatibility between the frontier molecular orbitals (HOMO and LUMO) of the alkenes and those of the generated reactive oxygen species (Fig. S12). The double bond length and the corresponding natural population analysis (NPA) during the first interaction with the O2 molecule were then calculated (Fig. S13). It can be observed that the most polarized double bond is that of the eight-membered ring (with the greatest NPA charge difference), and it is also the one that undergoes the most significant perturbation in the presence of oxygen. The NPA spin charge analysis shows that the spin density is mainly localized on the oxygen (triplet), although in the case of cyclohexene 11, it is slightly delocalized toward the alkene. Additionally, the system of two cyclododecene 7 molecules together, interacting through the alkene molecules in an orthogonal way, was computed (Fig. S14), and it was observed that the overlap of the HOMO and LUMO of both molecules causes a polarization of the electronic charge of the double bond, a fact that is consistent with the π–π stacking effect considered as an activating mechanism. DFT calculations by superimposing the alkene bonds failed to converge to a reasonable energy, which supports that the model where the alkene molecules are interacting in an orthogonal way is more plausible. Two molecules of cyclohexene 11 were also computed and, in contrast to cyclododecene 7 and for a similar intermolecular distance, the double bonds of both molecules of 11 tend to repel each other, the double bond stretching is minimal and orbital interaction is observed only in the LUMO, while the polarization of the NPA charges remains negligible, which might lead to the failure of the catalyst-free aerobic epoxidation reaction. We have also performed new calculations with three instead of two alkene molecules, one molecule above and another below the double bond. However, all calculations failed so far, either with cyclododecene 7 or cyclohexene 11, to converge to a reasonable energy, since the calculation is quite demanding. This work will be continued in the next studies.

To assess the efficiency and potential industrial applicability of the procedure, we calculated the E factor (kg of laurolactam 1 per kg of waste generated).20 The value for the present one-pot process compares very favorably with that of the current industrial method8b (1.7 vs. 16.2, respectively; Table S4), even if we start both procedures with cyclododecatriene (3.2 vs. 16.2), highlighting the efficiency and environmental advantage of the synthetic route reported herein.

Conclusions

In summary, the synthesis of laurolactam 1 from cyclododecene 7 has been achieved in good yield after a one-pot epoxidation, Meinwald rearrangement, oximation and Beckmann rearrangement sequential reaction. The procedure described here is performed in a single step, eliminating the purification of intermediates such as cyclododecanone 3 and its corresponding oxime 2, and the generation of residues such as sulfated salts and wastewater. It is true that the system here requires to prepare cyclododecene 7 from cyclododecatriene 6, which is not trivial, since the conversion of the cyclic triene to the single alkene compound is challenging and initially a mixture with the diene is formed, requiring yet further purification steps; however, we think that an opportunity arises with our system here to prepare laurolactam 1 in a more sustainable synthetic pathway.

Author contributions

S. H.-A. performed the cascade reactions and the DFT calculations. S. R.-N. performed the cascade reactions. J. O.-M. designed the experiments and supervised the project. A. L.-P. designed the experiments and supervised the whole work. The manuscript has been written with contributions from all authors, which also interpreted all the experimental parts.

Conflicts of interest

A Spanish patent (number P202431009) covering the cascade reaction here reported has been filed, with all the authors in this work appearing as co-inventors.

Data availability

The datasets generated during and/or analysed during the current study are included in this published article (and its supplementary information (SI) files) or available from the corresponding author on reasonable request.

Supplementary information: experimental section, Tables S1–S5, Fig. S1–S17, compound characterization, computational cartesian coordinates and additional references. See DOI: https://doi.org/10.1039/d5cy01180a.

Acknowledgements

Financial support by project PID2023-148441NB-I00, the Severo Ochoa Centre of Excellence program (CEX2021-001230-S, both from MCIINN), and INNEST/2022/20 (from Agència Valenciana de la Innovació, Generalitat Valenciana) are gratefully acknowledged. S. H.-A. thanks ITQ (UPV-CSIC) for the concession of a contract (FPI-2022-S2-42040). S. R.-N. thanks Agència Valenciana de la Innovació for a contract. J. O.-M. thanks the MICIIN for the concession of the Ramón y Cajal contract RYC2022-036154-I (funded by MCIN/AEI/10.13039/501100011033). We thank Dr M. Boronat for unvaluable helping during the DFT calculations.

Notes and references

  1. A. B. Fernández, A. Marinas, T. Blasco, V. Fornés and A. Corma, J. Catal., 2006, 243, 270–277 CrossRef.
  2. J. Kim, J. Park, J. Park and K. Song, US11358923B2, 2022.
  3. P. Rubio-Marqués, J. C. Hernández-Garrido, A. Leyva-Pérez and A. Corma, Chem. Commun., 2014, 50, 1645–1647 RSC.
  4. (a) G. Rajendran, US2009/0240068A1, 2009; (b) J. S. Yoo, J. H. Lee, J. S. Lim and S. H. Kim, WO2014/191589A1, 2014.
  5. (a) H. W. Geluk, V. G. Keizer, L. Foley, W. Jackson and A. Brossi, Org. Synth., 1973, 5, 281 Search PubMed; (b) S. Matsubara, H. Matsuda, T. Hamatani and M. Schlosser, Tetrahedron, 1988, 44, 2855–2863 CrossRef CAS; (c) P. Rullière, S. Carret, A. Milet and J.-F. Poisson, Chem. – Eur. J., 2015, 21, 3876–3885 CrossRef; (d) A. S. Singh and A. Leyva-Pérez, Org. Chem. Front., 2024, 11, 1124–1131 RSC.
  6. P. G. Clark, E. N. Guidry, W. Y. Chan, W. E. Steinmetz and R. H. Grubbs, J. Am. Chem. Soc., 2010, 132, 3405–3412 CrossRef CAS PubMed.
  7. (a) J. Kim, J. Park, J. Park and K. Song, EP3875447A1, 2021;; (b) J. Kim, J. Park, J. Park and K. Song, KR20190080535A, 2019.
  8. (a) K. Micoine, R. Meier, J. Herwig, M. Roos, H. Häger, L. Cameretti and J. Döring, ES2689341T3, 2018; (b) J. Kim, Y. Kim, J. Park, J. Park, H. Seo, S. Hyeong and K. Song, US2023073615A1, 2023; (c) Y. Kon, T. Nakashima, Y. Makino, H. Nagashima, S. Onozawa, S. Kobayashi and K. Sato, Adv. Synth. Catal., 2023, 365, 3227–3233 CrossRef CAS; (d) O. Kwon, D. S. Potts and D. W. Flaherty, Appl. Catal., B, 2024, 354, 124119 CrossRef CAS.
  9. (a) A. Leyva-Pérez, J. R. Cabrero-Antonino and A. Corma, Tetrahedron, 2010, 66, 8203–8209 CrossRef; (b) S. Sanz-Navarro, M. Mon, A. Doménech-Carbó, R. Greco, J. Sánchez-Quesada, E. Espinós-Ferri and A. Leyva-Pérez, Nat. Commun., 2022, 13, 2831 CrossRef CAS; (c) A. Lumbreras-Teijeiro, M. Bacic, J. Oliver-Meseguer and A. Leyva-Pérez, Chem. – Eur. J., 2022, 28, e202202421 CrossRef CAS; (d) C. Bilanin, A. S. Singh, L. Martínez-Belenguer and A. Leyva-Pérez, JACS Au, 2024, 4, 3284–3294 CrossRef CAS PubMed.
  10. (a) Y. Nishiyama, Y. Nakagawa and N. Mizuno, Angew. Chem., Int. Ed., 2001, 40, 3639–3641 CrossRef CAS; (b) A. G. Stamoulis, D. L. Bruns and S. S. Stahl, J. Am. Chem. Soc., 2023, 145, 17515–17526 CrossRef CAS.
  11. (a) H. Nozaki and R. Noyori, J. Org. Chem., 1965, 30, 1652–1654 CrossRef CAS; (b) J. R. Sanderson, L. W. Watts Jr. and T. L. Renken, US4517374A, 1985; (c) A. K. Suresh, M. M. Sharma and T. Sridhar, Ind. Eng. Chem. Res., 2000, 39, 3958–3997 CrossRef CAS; (d) H. Alshammari, P. J. Miedziak, D. W. Knight, D. J. Willock and G. J. Hutchings, Catal. Sci. Technol., 2013, 3, 1531–1539 RSC.
  12. S. Hervàs-Arnandis, F. Garnes-Portolés, S. Rodríguez-Nuévalos, J. Oliver-Meseguer and A. Leyva-Pérez, Nat. Commun., 2025, 16, 6542 CrossRef.
  13. (a) S. S. Mahajan, M. M. Sharma and T. Sridhar, Ind. Eng. Chem. Res., 2004, 43, 3289–3296 CrossRef CAS; (b) S. M. Mahajani, M. M. Sharma and T. Sridhar, Chem. Eng. Sci., 1999, 54, 3967–3976 CrossRef CAS; (c) P. E. Correa, G. Hardy and D. P. Riley, J. Org. Chem., 1988, 53, 1695–1702 CrossRef CAS; (d) M.-Y. Li, J. Li, A. Gu, X.-M. Nong, S. Zhai, Z.-Y. Yue, C.-G. Feng, Y. Liu and G.-Q. Lin, Green Chem., 2023, 25, 7073–7078 RSC.
  14. T. Sato, Y. Hamada, M. Sumikawa, S. Araki and H. Yamamoto, Ind. Eng. Chem. Res., 2014, 53, 19331–19337 CrossRef CAS.
  15. (a) S. M. Mahajani, M. M. Sharma and T. Sridhar, Chem. Eng. Sci., 1999, 54, 3967–3976 CrossRef CAS; (b) H. Alshammari, P. J. Miedziak, D. W. Knight, D. J. Willock and G. J. Hutchings, Catal. Sci. Technol., 2013, 3, 1531–1539 RSC.
  16. (a) J. A. Elings, H. E. B. Lempers and R. A. Sheldon, Eur. J. Org. Chem., 2000, 2000, 1905–1911 CrossRef; (b) A. Gonzalez-de-Castro and J. Xiao, J. Am. Chem. Soc., 2015, 137, 8206–8218 CrossRef CAS PubMed.
  17. D. F. Taber and P. J. Straney, J. Chem. Educ., 2010, 87, 1392 CrossRef CAS.
  18. (a) V. L. Mamedova and G. Z. Khikmatova, Chem. Heterocycl. Compd., 2017, 53, 976–978 CrossRef CAS; (b) T. Blasco, A. Corma, S. Iborra, I. Lezcano-González and R. Montón, J. Catal., 2010, 275, 78–83 CrossRef CAS; (c) M. Sharghi and H. H. Mona, Synthesis, 2002, 2002, 1057–1060 CrossRef; (d) H. Ichihashi and H. Sato, Appl. Catal., A, 2001, 221, 359–366 CrossRef CAS.
  19. (a) E. Rancan, F. Aricò, G. Quartarone, L. Ronchin, P. Tundo and A. Vavasori, Catal. Commun., 2014, 54, 11–16 CrossRef CAS; (b) T. Moriai, T. Tsukamoto, M. Tanabe, T. Kambe and K. Yamamoto, Angew. Chem., Int. Ed., 2020, 59, 23051–23055 CrossRef CAS; (c) Y. Wu, X. Tang, J. Zhao, C. Ma, L. Yun, Z. Yu, B. Song and Q. Meng, ACS Sustainable Chem. Eng., 2019, 8, 1178–1184 CrossRef; (d) A. Maranzana, G. Ghigo and G. Tonachini, J. Org. Chem., 2003, 68, 3125–3129 CrossRef CAS PubMed; (e) A. G. Leach, K. N. Houk and C. S. Foote, J. Org. Chem., 2008, 73, 8511–8519 CrossRef CAS PubMed.
  20. A. Leyva-Pérez, P. García-García and A. Corma, Angew. Chem., Int. Ed., 2014, 53, 8687–8690 CrossRef.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.